Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection, analysis indicates
Tuesday, October 23, 2012 - 10:30
in Health & Medicine
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, a new analysis indicates.